AMY BRETTMANN: Open Payments
NPI 1164824744 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,258 in 118 payments from 22 companies in 2025. Trend: 2023 $3,237 · 2024 $3,294 · 2025 $2,258
Food & beverage: $2,258
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $303 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $226 |
| Janssen Biotech, Inc. | 10 | $206 |
| PFIZER INC. | 11 | $185 |
| Ardelyx, Inc. | 8 | $161 |
| Lilly USA, LLC | 8 | $154 |
| SHIELD THERAPEUTICS INC | 2 | $133 |
| QOL Medical, LLC | 5 | $112 |
| Madrigal Pharmaceuticals | 6 | $106 |
| GENZYME CORPORATION | 3 | $90 |
Products named: TREMFYA, SKYRIZI, XELJANZ, IBSRELA, OMVOH, DUPIXENT, ENTYVIO, ACCRUFER.
Industry payments across KS — which companies pay providers there.
